Right to Try Requests and Oncologists’ Gatekeeping Obligations

Fernandez Lynch H, Sarpatwari A, Vonderheide RH, Zettler PJ - Journal of Clinical Oncology

  • Price, Value, and Access
  • Regulation and Clinical Evidence

Summary:

Oncologists will be at the forefront of Right to Try requests given the strong demand for pre-approval access to cancer therapies, and physicians face difficult gatekeeping obligations in managing patient expectations while navigating a law that removes FDA and IRB oversight from the access process.

VIEW SOURCE

Recent Work from PORTAL

Simple graphic of magnifying glass examining papers to signify reviewing research publications.

Pharmaceutical Industry Pay-Per-Click Advertising Strategies to Influence Public Opinions on Drug Pricing

Eisenkraft Klein D, Kesselheim AS - Clinical Pharmacology & Therapeutics

  • Price, Value, and Access
Talk bubble graphics representing commentary and opinion.

How Congress Can Fix Expert Advisory Committees

Daval CJR, Kesselheim AS - STAT

  • Regulation and Clinical Evidence
Simple graphic of magnifying glass examining papers to signify reviewing research publications.

Coverage and Costs for Medications After Medicare Price Negotiation

Cai CL, Bucha S, Kesselheim AS, Rome BN - Journal of General Internal Medicine

  • Price, Value, and Access